Document is current
Any future updates will be listed below
-
Authors
Moiseiwitsch, Nina A. https://orcid.org/0000-0001-7406-0258
Pandit, Sanika
Zwennes, Nicole
Nellenbach, Kimberly
Sheridan, Ana https://orcid.org/0000-0003-0255-6929
LeGrand, Jessica
Chee, Eunice
Ozawa, Sarah
Troan, Brigid
Aw, Wen Yih
Polacheck, William https://orcid.org/0000-0003-2728-0746
Haider, Mansoor A.
Brown, Ashley C. https://orcid.org/0000-0001-6995-1785
-
Funding
Funding for this research was provided by:
National Science Foundation (CMMI 2235857; DGE-2137100)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01HL146701; 5F30HL163869)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (5T34GM131947-05; 5T32GM133366)
- License Information
-
More Information
Article History
Received: 12 February 2024
Accepted: 20 March 2025
First Online: 8 April 2025
Competing interests
: ACB is co-founder of Selsym Biotech Inc., a start-up company that focuses on clinical translation of hemostatic materials. ACB, NM, KN, and SP are inventors on a US Patent Application (18/921,390) titled “Colloidal Fibrin Nanoparticle Compositions and Uses” submitted by NC State University related to the materials described in this manuscript. All other authors declare no competing interests.
